Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
27.98
+1.15 (4.29%)
At close: Nov 6, 2026, 4:00 PM EST
27.51
-0.47 (-1.68%)
After-hours: Nov 6, 2026, 7:30 PM EST
Adaptive Biotechnologies Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Adaptive Biotechnologies stock has a consensus rating of "Strong Buy" and an average price target of $30.21. The average 1-year stock price forecast is 7.97% higher than the current stock price, while the lowest is $21 (-24.95%) and the highest is $35 (+25.09%).
Price Target: $30.21 (+7.97%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Adaptive Biotechnologies stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 6 | 6 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Buy Reiterates $34 | Buy | Reiterates | $34 | +21.52% | Nov 6, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $32 → $34 | Buy | Reiterates | $32 → $34 | +21.52% | Nov 5, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $28 | Buy | Maintains | $28 | -1.72% | Nov 5, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $27 → $30 | Buy | Maintains | $27 → $30 | +7.22% | Oct 14, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $22 → $27 | Hold | Maintains | $22 → $27 | -3.50% | Oct 13, 2026 |
Financial Forecast
Revenue This Year
293.25M
from 276.98M
Increased by 5.88%
Revenue Next Year
360.14M
from 293.25M
Increased by 22.81%
EPS This Year
-0.54
from -0.39
EPS Next Year
-0.18
from -0.54
EPS and Forward PE are based on non-GAAP adjusted numbers.